Login / Signup

The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies.

Chiara AzzariVincenzo BaldoSandro GiuffridaR GaniE O'BrienC AlimentiVincent J DanielsLara J Wolfson
Published in: ClinicoEconomics and outcomes research : CEOR (2020)
Varicella vaccination has a major impact on reducing varicella incidence, prevalence, and societal costs. This analysis supports the policy for universal varicella vaccination in Italy as the NV strategy was the most expensive and resulted in the poorest outcomes. QQVa offers the greatest benefits at the lowest cost and should be considered as a potential priority strategy for Italian population.
Keyphrases
  • risk factors
  • public health
  • healthcare
  • type diabetes
  • metabolic syndrome
  • adipose tissue
  • insulin resistance